Clinical Trial Update: New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) [NA]

View source ↗

Summary

A completed clinical trial comparing a new MAL-PDT regimen to an approved MAL-PDT regimen for basal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Methyl aminolevulinate photodynamic therapy (methyl aminolevulinate)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Skin Neoplasms, Carcinoma, Basal Cell | NA | Status: COMPLETED